Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Clinical Study of Rhythmic Auditory Stimulation for Gait Disorders

N/AEnrolling By InvitationNCT06837038
YiCheng Zhu60 enrolled

Overview

The aim of this clinical trial was to determine whether rhythmic auditory stimulation is effective in treating gait disorders in patients with post-stroke hemiplegia, primary Parkinson's disease, and various parkinsonism syndromes. The main questions it aims to answer are: Does rhythmic auditory stimulation increase walking speed in patients with gait disorders? To determine whether rhythmic auditory stimulation is effective in treating gait disorders, researchers will compare a gait rhythmometer with an active control that does not receive rhythmic stimulation. Participants will: Gait training was conducted once a day for 15 minutes for 7 consecutive days Resting-state functional magnetic resonance imaging (fmri) was performed before and after treatment Feedback on subjective improvement at the end of the 7-day treatment

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

60

Conditions

Hemiplegia Due to StrokeParkinson DiseaseParkinsonian Syndrome

Interventions

rhythmic auditory stimulationDEVICE

The intervention group was treated with a gait rhythm device under the supervision of the researchers. The complete gait training was conducted once a day for 15 minutes for 7 consecutive days. Each patient wore inertial sensors at both ankles during gait training to collect gait information during walking.

No rhythm stimulationDEVICE

The control group received gait training without rhythmic auditory stimulation under the supervision of the researchers. The complete gait training was conducted once a day for 15 to 20 minutes for 7 consecutive days. Each patient wore inertial sensors at both ankles during gait training to collect gait information during walking.

Eligibility

Sex: ALLMin age: 50 YearsMax age: 80 Years
Medical Language ↔ Plain English
For post-stroke hemiplegia Inclusion criteria : * Age 50-80 years old * One or more strokes (cerebral infarction or cerebral hemorrhage), with the most recent stroke occurring at least 6 months earlier * Walking independently without a cane or walking aid with obvious gait asymmetry * 0.4m/s\< baseline velocity \<0.8m/s * Sufficient hearing, vision and comprehension to complete motor function tests * Patients were willing and able to participate in all study procedures and signed informed consent * No other rehabilitation treatment was received at present Exclusion Criteria: * Unable to cooperate with the motor function test * Uncontrolled hypertension * Myocardial infarction within the past 3 months * With bone and joint diseases, such as a history of lower limb fracture within 1 year, waist and lower limb bone and joint surgery, bone and joint deformity seriously affecting walking, etc. * Except for stroke, there was no parkinsonism, myasthenia gravis, poliomyelitis and other nervous system diseases affecting the walking function of patients. For primary Parkinson's disease (PD) Inclusion criteria: * Age 50-80 years old * PD met the diagnostic criteria of Chinese Diagnostic Criteria for Parkinson's Disease (2016 edition) * Obvious panic gait, freezing gait or slow gait, but can walk independently without the use of a cane or walking aid * Hoehn-Yahr (H-Y) stage 2-4 * 0.4m/s\< baseline velocity \<0.8m/s * Sufficient hearing, vision and comprehension to complete motor function tests * Patients were willing and able to participate in all study procedures and signed informed consent * No other rehabilitation treatment was received at present Exclusion criteria: * Unable to cooperate with the motor function test * Uncontrolled hypertension * Myocardial infarction within the past 3 months * With bone and joint diseases, such as a history of lower limb fracture within 1 year, waist and lower limb bone and joint surgery, bone and joint deformity seriously affecting walking, etc * There was no stroke, myasthenia gravis, poliomyelitis and other neurological diseases affecting the walking function except for primary Parkinson's disease For Parkinsonism syndrome: Inclusion criteria: * Age 50-80 years old * All parkinsonism syndrome except primary Parkinson's disease, including but not limited to drug-induced parkinsonism, multiple system atrophy, cerebral small vessel disease-related parkinsonism, etc * obvious panic gait, freezing gait or slow gait, but can walk independently without the use of a cane or walking aid * 0.4m/s\< baseline velocity \<0.8m/s * Sufficient hearing, vision and comprehension to complete motor function tests * Be willing and able to participate in all study procedures and sign informed consent * No other rehabilitation treatment was received at present. Exclusion criteria: * Unable to cooperate with the motor function test * Uncontrolled hypertension * Myocardial infarction within the past 3 months * With bone and joint diseases, such as a history of lower limb fracture within 1 year, waist and lower limb bone and joint surgery, bone and joint deformity seriously affecting walking, etc * There was no stroke, myasthenia gravis, poliomyelitis and other neurological diseases that affected the walking function except for parkinsonism

Locations (1)

Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Beijing, Beijing Municipality, China

Outcomes

Primary Outcomes

Gait speed

The difference between the gait speed measured on the third day after the completion of the seven gait sessions and the baseline gait speed

Time frame: 10 days

Secondary Outcomes

Stride length

The difference between the stride length (left and right) measured on the third day after the completion of the seven gait sessions and the baseline stride length.

Time frame: 10 days

Stride frequency

The difference between the stride frequency (left and right) measured on the third day after the completion of the seven gait sessions and the baseline stride frequency.

Time frame: 10 days

Stride speed

The difference between the stride speed (left and right) measured on the third day after the completion of the seven gait sessions and the baseline stride speed.

Time frame: 10 days

Swing speed

The difference between the swing speed (left and right) measured on the third day after the completion of the seven gait sessions and the baseline swing speed.

Time frame: 10 days

Standing phase

The difference between the standing phase (left and right) measured on the third day after the completion of the seven gait sessions and the baseline standing phase.

Time frame: 10 days

Turn time

The difference between the turn time measured on the third day after the completion of the seven gait sessions and the baseline turn time.

Time frame: 10 days

Patient's SUBJECTIVE assessment

All subjects were asked about their subjective feelings using a uniform questionnaire, including the following questions: Did the patient's gait problems improve after 7 days of treatment? If there has been improvement, in what ways? (Step speed, stride length, symmetry, turn time, etc.)

Time frame: 10 days

Resting-state functional magnetic resonance imaging

At baseline and on the third day after completion of the 7-day gait treatment, 3T resting-state functional magnetic resonance imaging (rs-fMRI) was performed to compare the changes of local neural activity, including amplitude of low frequency fluctuation (ALFF) and functional connectivity density (FCD).

Time frame: 10 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.